You are here

Merck

Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinical Trials Evaluating Investigational Elbasvir/Grazoprevir in Hepatitis C

Yahoo

Sun, 11/15/15 - 11:39 am

clinical trials

elbasvir/grazoprevir

Merck may appeal to Supreme Court after again losing fight to protect Cubicin patents

Fierce Pharma

Sat, 11/14/15 - 11:17 am

Drug makers beat diabetes lawsuits with an unusual ruling

Pharmalot

Fri, 11/13/15 - 08:49 pm

Panel recommends Merck continue cholesterol drug study

Yahoo/Reuters

Fri, 11/13/15 - 10:03 am

advisory panels

U.S. appeals court invalidates four Merck Cubicin patents

Yahoo/Reuters

Thu, 11/12/15 - 02:17 pm

Merck & Co. Versus AbbVie: Who Is the Winner and Who Is the Loser?

Yahoo/GuruFocus

Thu, 11/12/15 - 01:40 pm

Gardasil Is Driving Merck’s Vaccine Business

Yahoo/Market Realist

Thu, 11/12/15 - 01:39 pm

Januvia and Janumet: Merck’s Blockbuster Diabetes Products

Yahoo/Market Realist

Thu, 11/12/15 - 09:19 am

A Trio of Catalysts Lift Merck Higher in October

Motley Fool

Wed, 11/11/15 - 10:00 am

grazoprevir/elbasvir

Lilly, Merck join Valeant in DOJ spotlight with new inquiries on pricing

Fierce Pharma

Tue, 11/10/15 - 09:33 am

Valeant Pharmaceuticals

FDA panel backs Merck & Co drug to reverse muscle relaxant effect

Yahoo/Reuters

Fri, 11/6/15 - 03:28 pm

HPV vaccine not linked to chronic pain or fainting: European regulators

Pharmalot

Thu, 11/5/15 - 12:50 pm

GSK and Merck to Study Immunotherapy Combination as Potential Cancer Treatment

Yahoo

Tue, 11/3/15 - 02:17 pm

cancer immunotherapy

Merck Phase 2 Trials: Climb One Step At A Time

Bidness, ETC

Mon, 11/2/15 - 06:02 pm

Merck chief Frazier's R&D-based drug price defense a tough sell for pharma

BioPharma Dive

Mon, 11/2/15 - 11:05 am

Kenneth Frazier

Merck Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for KEYTRUDA® (pembrolizumab) in Advanced Colorectal Cancer

Yahoo

Mon, 11/2/15 - 10:04 am

colorectal cancer

The top 10 biopharma pipeline disasters of 2015

Fierce Biotech

Fri, 10/30/15 - 09:55 am

Merck's Keytruda has a shot at a bigger share of NSCLC sales

Fierce Pharma Marketing

Wed, 10/28/15 - 02:59 pm

non-small cell lung cancer

Bristol-Myers Squibb

Merck says it won't need AbbVie-sized discounts to win in hep C

Fierce Pharma Marketing

Wed, 10/28/15 - 09:56 am

Merck CEO discussed drug prices with Obama

CNBC

Tue, 10/27/15 - 09:19 pm

Kenneth Frazier

Pages